Quotient Sciences
Ruddington, Nottingham, NG11 6JS, United Kingdom
NCT Number: NCT05320861
This single centre, open-label, non-randomised, single period, single-dose study in healthy male subjects was designed and conducted to assess the mass balance recovery, PK, metabolite profile and metabolite identification of SJP-0008.
Looking for future studies?
Notify Me50 year–70 year
Male
Interventional
Phase 1
Ruddington, Nottingham, NG11 6JS, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other protocol-defined exclusion criteria may apply
Single oral dose of [14C]SJP-0008
Time frame: Until the mass balance criteria for all participants have been met (estimated up to Day 10)
Mass balance recovery of total radioactivity in all excreta by analysing the total radioactivity and metabolic profile in plasma, urine and faeces samples.
Time frame: Up to Day 8
Time frame: Up to Day 8
Time frame: Up to Day 8
Time frame: Up to Day 8
Time frame: Up to Day 8
Time frame: Up to Day 8
Time frame: Up to Day 8
Time frame: Until the mass balance criteria for all participants have been met (estimated up to Day 10)
Senju Pharmaceutical Co., Ltd.
Industry
A Single Dose Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism and Excretion of [14C]SJP-0008 in Healthy Male Subjects After an Oral Dose
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05447078
Healthy Volunteers, Infections
Jackson, Mississippi, United States
View Trial DetailsNCT07513532
Healthy Volunteers
Seattle, Washington, United States
View Trial DetailsNCT07090655
Healthy Volunteers
Brisbane, Australia
View Trial DetailsNCT01915212
Communicable Diseases, DNA Virus Infections
Bethesda, Maryland, United States
View Trial Details